Survey of hepatitis markers among donors in the State of Qatar

Qatar Medical Journal

Volumn 16, Issue 2, 2007, Pages 47-50

  Fawzi, Z ^a   Al Hilali, A ^a   Al Malki, A ^a   Al Matawa, H ^a   Yousef, B ^a   Ali Bin Ali, A ^a   Al Mansour, S ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; EGYPT; HEALTH SURVEY; HEPATITIS; HEPATITIS B VIRUS; HUMAN; INDIGENOUS PEOPLE; MASS SCREENING; PREVALENCE; QATAR;

EID: 53849089644     PISSN: 02538253     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fiona A.M. Regan, Patricia Hewitt, John, A.J. Barbara, Marcella Contreras (2000). Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood BMJ, 320 (7232), 403-406.
2. Jay E. Menitove (1996). Transfusion-Transmitted Infections: Update. Seminar in Hematology, Vol 33, No 4, 290-301.
3. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996). The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Eng J Med. 334 (26),1685-1690.
4. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hoi DE, O'Brien SE, Sher G (2003). Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T- cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ, 169 (8), 767-773.
5. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE (2000. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991-1996. JAMAI 248 (2), 238-240.
6. Adrian M Di Bisceglie (1998). Hepatitis C (Seminar). Lancet, 351, 351-355.
7. Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, Gilcher RO, Kleinman SH, Matijas L, Thomson RA (1996). Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA, 275 (13), 995-1000.
8. Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C (1994) Transfusion, 34 (2) 135-137.
9. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edeln R (1993). Risk factors associated with a high seroprevalence of hepatitis virus infection in Egyptian blood donors. Am J Trop Med & Hyg 49 (4), 440-447.
10. Quinti I, Renganathan E, El Ghazzawi E, Divizia M, Sawaf G, Awad Pana A, Rocchi G (1995). Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol, 283 (2), 239-244.
11. Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y et al. (2000). Hepatitis C in a community in Upper Egypt: 1. Cross-sectional survey. Am J Trop Med Hyg, 63(5-6), 236-241.
12. El Zayedi AR, Selim O, Ibrahim EH, Hamdy H, Dabbous H, Ahdy A, Moneim SA (1997). Does schistsomiasis play a role in the high sero-prevalence of HCV antibody among Egyptians? Trop Gastroenterol, 18 (3), 98-100.
13. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R (1996). High seroprevalence of hepatitis A, B, C and E viruses in residents in an Egyptian village in The Nile Delta: A pilot study. Am J Trop Med Hyg, 57 (3), 251.
14. Arthur RR, Hassan NF, Abdallah MY, el- Sharkawy MS, Saad MD, Hackbart BG, Imam IZ (1997). Hepatitis C anti-body prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg, 91 (3), 271-284.
15. Abdel Wahab MF, Zakaria S, Kamel M, Abdel Khaliq MK, Mabrouk MA, Salama H, Esmat G, Thomas DL, Strickland GT (1994). High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg, 51 (5), 563-567.
16. Kakepoto GN, Bhally HS, Khaliq G, Kayani N, Burney IA, Siddiqui Khurshid M (1996). Epidemiology of blood-borne viruses: A study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health, 27(4), 703-706.
17. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ (2002). Seroprevalence of hepatitis of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc, 52 (9), 398-402.
18. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N (2000). Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (ant-HCV) in Madurai, South India. Indian J Med Sci, 54 (7), 270-230.
19. Jain A, Rana SS, Chakravarty P, Gupta PK, Murthy NS, Nath MC, Gururaja S, Chatturvedi N, Verma U, Kar P (2003). The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol, 18 (7), 695-297.
20. Panigrahi AK, Panda SK, Dixit RK, Rao KV, Acharya SK, Dasarath, Nanu A (1997). Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver disease. med Virol, 51 (3), 167-174.
21. Garag S, Mathur DR, Garg DK (2001). Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol, 44 (4), 409-412.
22. Ghavanini AA, Sabri MR (2000). Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J, 6(5-6), 1114-1116.
23. Albert M. Lema, Edmundo A. Cox (1992). Hepatitis C Antibodies among Blood Donors in Qatar. Vox Sang, 63, 237.